Shankar Balasubramanian
Indian-born British chemist / From Wikipedia, the free encyclopedia
Sir Shankar Balasubramanian FRS FMedSci (born 30 September 1966)[1] is an Indian-born British chemist[5][6] and Herchel Smith Professor[7] of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge,[8][9] Senior Group Leader at the Cancer Research UK Cambridge Institute[10] and Fellow of Trinity College, Cambridge.[11] He is recognised for his contributions in the field of nucleic acids.[12] He is scientific founder of Solexa[13][14] and biomodal (formally Cambridge Epigenetix).[15][16]
Quick Facts Born, Nationality ...
Shankar Balasubramanian | |
---|---|
Born | (1966-09-30) 30 September 1966 (age 57)[1] |
Nationality | British |
Alma mater | University of Cambridge (MA, MSci, PhD) |
Known for |
|
Awards |
|
Scientific career | |
Institutions | |
Thesis | Studies on the reaction mechanism of chorismate synthase (1992) |
Doctoral advisor | Chris Abell |
Doctoral students | Julian Huppert[3][4] |
Website | www |
Close